2-METHYL-THIENO-BENZODIAZEPINE FORMULATION

PROBLEM TO BE SOLVED: To provide a pharmaceutically refined formulation containing olanzapine. SOLUTION: The formulation includes olanzapine pamoate or its solvate. The formulation exhibits a prolonged sustained release of more than 7 days and a burst release of less than 15% of the active component...

Full description

Saved in:
Bibliographic Details
Main Authors ALLEN DOUGLAS JAMES, BROOKS NORMAN DALE, HENDRIKSEN BARRY ARNOLD, MASCARENHAS SNEHLATA SINGH, SANCHEZ-FELIX MANUEL VICENTE, FERGUSON THOMAS HARRY, SHINKLE SHARON LOUISE, GARVIN STUART JAMES, MURRAY LINDA CAMERON, DEKEMPER KURT DOUGLAS, BUNNELL CHARLES ARTHUR, TUPPER DAVID EDWARD
Format Patent
LanguageEnglish
Published 24.06.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a pharmaceutically refined formulation containing olanzapine. SOLUTION: The formulation includes olanzapine pamoate or its solvate. The formulation exhibits a prolonged sustained release of more than 7 days and a burst release of less than 15% of the active component. COPYRIGHT: (C)2010,JPO&INPIT
Bibliography:Application Number: JP20100060704